Dipanjan Chowdhury

14.2k total citations · 5 hit papers
104 papers, 9.7k citations indexed

About

Dipanjan Chowdhury is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Dipanjan Chowdhury has authored 104 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 31 papers in Oncology and 29 papers in Cancer Research. Recurrent topics in Dipanjan Chowdhury's work include DNA Repair Mechanisms (38 papers), MicroRNA in disease regulation (24 papers) and PARP inhibition in cancer therapy (18 papers). Dipanjan Chowdhury is often cited by papers focused on DNA Repair Mechanisms (38 papers), MicroRNA in disease regulation (24 papers) and PARP inhibition in cancer therapy (18 papers). Dipanjan Chowdhury collaborates with scholars based in United States, Poland and United Kingdom. Dipanjan Chowdhury's co-authors include Judy Lieberman, Yunfeng Pan, Derek M. Dykxhoorn, Panagiotis A. Konstantinopoulos, Alan D. D’Andrea, Deborah Palliser, Ranjan Sen, Pengcheng Zhu, David Pellman and Stephen Buratowski and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Dipanjan Chowdhury

100 papers receiving 9.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA breaks and chromosome pulverization from errors in mitosis

2012 902 citations Karen Crasta, Neil J. Ganem et al. Nature profile →
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors

2005 808 citations Dipanjan Chowdhury et al. profile →
Death by a Thousand Cuts: Granzyme Pathways of Programmed Cell Death

2008 505 citations Dipanjan Chowdhury et al. profile →
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer

2016 451 citations Kyle C. Strickland, Brooke E. Howitt et al. profile →
Targeting replication stress in cancer therapy

2022 184 citations Dipanjan Chowdhury, Alan D. D’Andrea et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dipanjan Chowdhury United States	49	7.3k	2.6k	2.5k	1.7k	864	104	9.7k
Eva Hernando United States	52	10.6k 1.5×	5.6k 2.2×	3.3k 1.3×	2.0k 1.1×	811 0.9×	115	14.5k
Dik C. van Gent Netherlands	49	6.5k 0.9×	1.4k 0.6×	2.4k 1.0×	1.6k 0.9×	832 1.0×	109	9.0k
Robert Hromas United States	55	6.1k 0.8×	969 0.4×	2.7k 1.1×	2.7k 1.5×	1.2k 1.4×	207	10.4k
Bruno Calabretta United States	65	8.6k 1.2×	1.6k 0.6×	2.6k 1.1×	1.6k 0.9×	1.1k 1.2×	237	13.2k
Ronald J. Buckanovich United States	49	3.7k 0.5×	1.3k 0.5×	3.5k 1.4×	1.7k 1.0×	539 0.6×	123	7.2k
Henry C. Krutzsch United States	48	6.3k 0.9×	2.3k 0.9×	1.8k 0.7×	1.3k 0.7×	475 0.5×	111	9.7k
Jean‐Yves Masson Canada	49	7.9k 1.1×	1.2k 0.5×	2.8k 1.1×	421 0.2×	1.3k 1.5×	170	9.0k
Hong Wu United States	39	3.7k 0.5×	947 0.4×	3.2k 1.3×	1.2k 0.7×	477 0.6×	102	7.5k
Terry Van Dyke United States	40	4.5k 0.6×	1.1k 0.4×	3.0k 1.2×	742 0.4×	1.3k 1.5×	104	7.2k
Leonardo Salmena Canada	31	13.9k 1.9×	9.0k 3.5×	1.9k 0.8×	1.5k 0.9×	654 0.8×	66	16.6k

Countries citing papers authored by Dipanjan Chowdhury

Since Specialization

Citations

This map shows the geographic impact of Dipanjan Chowdhury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dipanjan Chowdhury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dipanjan Chowdhury more than expected).

Fields of papers citing papers by Dipanjan Chowdhury

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dipanjan Chowdhury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dipanjan Chowdhury. The network helps show where Dipanjan Chowdhury may publish in the future.

Co-authorship network of co-authors of Dipanjan Chowdhury

This figure shows the co-authorship network connecting the top 25 collaborators of Dipanjan Chowdhury. A scholar is included among the top collaborators of Dipanjan Chowdhury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dipanjan Chowdhury. Dipanjan Chowdhury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Symecko, Heather, et al.. (2026). Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations. Biomarker Research. 14(1). 9–9.

Chowdhury, Dipanjan, et al.. (2025). Neuroinflammatory disorders of the central nervous system associated with monkeypox virus: a systematic review and call to action. BMC Medicine. 23(1). 86–86. 1 indexed citations

Tsaousidou, Eva, Pascal Drané, Zhe Cao, et al.. (2024). Endogenous p53 inhibitor TIRR dissociates systemic metabolic health from oncogenic activity. Cell Reports. 43(6). 114337–114337. 2 indexed citations

Chowdhury, Dipanjan, et al.. (2024). Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and Prognostics. International Journal of Molecular Sciences. 25(20). 10911–10911. 9 indexed citations

Zheng, Xiao-Feng, Aleem Syed, Huy Nguyen, et al.. (2024). CDK5–cyclin B1 regulates mitotic fidelity. Nature. 633(8031). 932–940. 4 indexed citations

Sun, Yajie, Jeffrey Patterson-Fortin, Sen Han, et al.. (2024). 53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer. Nature Communications. 15(1). 6676–6676. 10 indexed citations

Russell, Trinity, et al.. (2024). Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer. Cancer Epidemiology Biomarkers & Prevention. 34(3). 385–393.

Elias, Kevin M., Konrad Stawiski, Zuzanna Nowicka, et al.. (2023). Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles. Nature Communications. 14(1). 3350–3350. 11 indexed citations

Zhou, Rui, Aleem Syed, Lisa A. Moreau, et al.. (2023). Dynamics of the DYNLL1–MRE11 complex regulate DNA end resection and recruitment of Shieldin to DSBs. Nature Structural & Molecular Biology. 30(10). 1456–1467. 19 indexed citations

10.

Adhikary, Utsarga, João A. Paulo, Marina Godes, et al.. (2023). Targeting MCL-1 triggers DNA damage and an anti-proliferative response independent from apoptosis induction. Cell Reports. 42(10). 113176–113176. 9 indexed citations

11.

Nowicka, Zuzanna, Bartłomiej Tomasik, David Kozono, et al.. (2023). Serum miRNA-based signature indicates radiation exposure and dose in humans: A multicenter diagnostic biomarker study. Radiotherapy and Oncology. 185. 109731–109731. 3 indexed citations

12.

Pal, Sharmistha, David Kozono, Xiaodong Yang, et al.. (2018). Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas. Cancer Research. 78(14). 4007–4021. 71 indexed citations

13.

Elias, Kevin M., Wojciech Fendler, Konrad Stawiski, et al.. (2017). Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer. eLife. 6. 107 indexed citations

14.

Howitt, Brooke E., Kyle C. Strickland, Lynette M. Sholl, et al.. (2017). Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression. OncoImmunology. 6(2). e1277308–e1277308. 86 indexed citations

15.

Moskwa, Patryk, Pascal O. Zinn, Young Eun Choi, et al.. (2014). A Functional Screen Identifies miRs That Induce Radioresistance in Glioblastomas. Molecular Cancer Research. 12(12). 1767–1778. 24 indexed citations

16.

Wang, Meng, Patricia Greninger, Anurag Singh, et al.. (2014). EGFR-Mediated Chromatin Condensation Protects KRAS-Mutant Cancer Cells against Ionizing Radiation. Cancer Research. 74(10). 2825–2834. 55 indexed citations

17.

Crasta, Karen, Neil J. Ganem, Alexandra B. Lantermann, et al.. (2012). DNA breaks and chromosome pulverization from errors in mitosis. Nature. 482(7383). 53–58. 902 indexed citations breakdown →

18.

Benassi, Barbara, Richard Flavin, Luigi Marchionni, et al.. (2012). MYC Is Activated by USP2a-Mediated Modulation of MicroRNAs in Prostate Cancer. Cancer Discovery. 2(3). 236–247. 80 indexed citations

19.

Chakraborty, Tirtha, Dipanjan Chowdhury, Anant Jani, et al.. (2007). Repeat Organization and Epigenetic Regulation of the DH-Cμ Domain of the Immunoglobulin Heavy-Chain Gene Locus. Molecular Cell. 27(5). 842–850. 66 indexed citations

20.

Chowdhury, Dipanjan & Ranjan Sen. (2004). Regulation of immunoglobulin heavy‐chain gene rearrangements. Immunological Reviews. 200(1). 182–196. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact